• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

EASL Recommendations on Treatment of Hepatitis C 2018.

出版信息

J Hepatol. 2018 Aug;69(2):461-511. doi: 10.1016/j.jhep.2018.03.026. Epub 2018 Apr 9.

DOI:10.1016/j.jhep.2018.03.026
PMID:29650333
Abstract
摘要

相似文献

1
EASL Recommendations on Treatment of Hepatitis C 2018.2018年欧洲肝脏研究学会丙型肝炎治疗推荐意见
J Hepatol. 2018 Aug;69(2):461-511. doi: 10.1016/j.jhep.2018.03.026. Epub 2018 Apr 9.
2
[Standard treatment of acute and chronic hepatitis C].[急性和慢性丙型肝炎的标准治疗]
Z Gastroenterol. 2004 Aug;42(8):714-9. doi: 10.1055/s-2004-813444.
3
[Diagnosis and treatment of acute and chronic hepatitis C--procedure in difficult situations].[急慢性丙型肝炎的诊断与治疗——困难情况下的诊疗流程]
Z Gastroenterol. 2004 Aug;42(8):720-3. doi: 10.1055/s-2004-813445.
4
EASL recommendations on treatment of hepatitis C: Final update of the series.EASL 丙型肝炎治疗建议：系列的最终更新。
J Hepatol. 2020 Nov;73(5):1170-1218. doi: 10.1016/j.jhep.2020.08.018. Epub 2020 Sep 15.
5
Treatment of chronic hepatitis C.慢性丙型肝炎的治疗
Compr Ther. 1997 Apr;23(4):269-76.
6
[Definition and diagnosis of acute and chronic hepatitis C].[急性和慢性丙型肝炎的定义与诊断]
Z Gastroenterol. 2004 Aug;42(8):705-6. doi: 10.1055/s-2004-813442.
7
[Criteria for the definition of acute and chronic hepatitis C].[急性和慢性丙型肝炎的定义标准]
Z Gastroenterol. 2004 Aug;42(8):707-13. doi: 10.1055/s-2004-813443.
8
EASL Clinical Practice Guidelines: management of hepatitis C virus infection.欧洲肝脏研究学会临床实践指南：丙型肝炎病毒感染的管理
J Hepatol. 2011 Aug;55(2):245-64. doi: 10.1016/j.jhep.2011.02.023. Epub 2011 Mar 1.
9
Hepatitis C.丙型肝炎
Ann Emerg Med. 1998 Mar;31(3):381-90. doi: 10.1016/s0196-0644(98)70351-8.
10
Proceeding Report of Joint Meeting of Nepalese Association for the Studies of the Liver and Nepalese Society of Gastroenterologists on Overcoming the Challenges for Hepatitis C Virus Elimination in Nepal by 2030.尼泊尔肝脏研究协会与尼泊尔胃肠病学家协会联席会议关于在2030年前消除尼泊尔丙型肝炎病毒挑战的进展报告
JNMA J Nepal Med Assoc. 2017 Apr-Jun;56(206):288-290.

引用本文的文献

1
MRI-based machine-learning radiomics of the liver to predict liver-related events in hepatitis B virus-associated fibrosis.基于磁共振成像的肝脏机器学习影像组学预测乙型肝炎病毒相关肝纤维化中的肝脏相关事件
Eur Radiol Exp. 2025 Aug 27;9(1):81. doi: 10.1186/s41747-025-00602-0.
2
A fully automated, ultrasensitive luminescence cascade sensor to address hepatitis C diagnostic disparity.一种用于解决丙型肝炎诊断差异的全自动超灵敏发光级联传感器。
Innovation (Camb). 2025 May 15;6(8):100952. doi: 10.1016/j.xinn.2025.100952. eCollection 2025 Aug 4.
3
Pathogenesis, prevention, and therapeutic advances in hepatitis B, C, and D.
乙型、丙型和丁型肝炎的发病机制、预防及治疗进展
Virol J. 2025 Aug 11;22(1):274. doi: 10.1186/s12985-025-02907-3.
4
Hepatitis C Virus Cascade of Care After the Introduction of Direct-Acting Antiviral Medications in Suriname.苏里南引入直接抗病毒药物后丙型肝炎病毒的连续治疗
Cureus. 2025 Jun 27;17(6):e86873. doi: 10.7759/cureus.86873. eCollection 2025 Jun.
5
Efficiency and safety of sofosbuvir in Bangladeshi children with chronic hepatitis C virus infection.索磷布韦治疗孟加拉国慢性丙型肝炎病毒感染儿童的有效性和安全性。
ILIVER. 2023 Jul 28;2(3):146-150. doi: 10.1016/j.iliver.2023.06.002. eCollection 2023 Sep.
6
Long-Term Outcomes of Ledipasvir/Sofosbuvir Treatment in Hepatitis C: Viral Suppression, Hepatocellular Carcinoma, and Mortality in Mongolia.来迪派韦/索磷布韦治疗丙型肝炎的长期结果：蒙古的病毒抑制、肝细胞癌和死亡率
Viruses. 2025 May 22;17(6):743. doi: 10.3390/v17060743.
7
Oral manifestations in patients with chronic hepatitis C.慢性丙型肝炎患者的口腔表现。
BMC Oral Health. 2025 Jun 9;25(1):944. doi: 10.1186/s12903-025-06307-5.
8
TeleHCV: A single-visit protocol and minimal passive remote monitoring are sufficient to achieve high SVR with a sofosbuvir-velpatasvir regimen.远程丙肝治疗：采用索磷布韦-维帕他韦方案时，单次就诊方案及最低限度的被动远程监测足以实现高持续病毒学应答率。
Clinics (Sao Paulo). 2025 Apr 23;80:100643. doi: 10.1016/j.clinsp.2025.100643. eCollection 2025.
9
Prescription patterns of comedications associated with drug-drug interactions risk in HCV-infected patients undergoing direct-acting antiviral treatment: an analysis of an administrative claims database in Japan.接受直接抗病毒治疗的丙型肝炎病毒感染患者中与药物相互作用风险相关的合并用药处方模式：日本一项行政索赔数据库分析
J Pharm Health Care Sci. 2025 Apr 18;11(1):33. doi: 10.1186/s40780-025-00442-5.
10
The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions.病毒性肝炎向肝细胞癌的恶性转化：机制与干预措施
MedComm (2020). 2025 Mar 8;6(3):e70121. doi: 10.1002/mco2.70121. eCollection 2025 Mar.